Terms: = Cervical cancer AND CBFA2T3, ETO2, 863, ENSG00000129993, ZMYND4, MTGR2, MTG16 AND Staging
3 results:
1. Retrospective analysis of the incidence and predictive factors of parametrial involvement in FIGO IB1 cervical cancer.
Yang Q; Zhou Q; He X; Cai J; Sun S; Huang B; Wang Z
J Gynecol Obstet Hum Reprod; 2021 Oct; 50(8):102145. PubMed ID: 33848645
[TBL] [Abstract] [Full Text] [Related]
2. SUVmax of 18FDG PET/CT as a predictor of high-risk endometrial cancer patients.
Antonsen SL; Loft A; Fisker R; Nielsen AL; Andersen ES; Høgdall E; Tabor A; Jochumsen K; Fagö-Olsen CL; Asmussen J; Berthelsen AK; Christensen IJ; Høgdall C
Gynecol Oncol; 2013 May; 129(2):298-303. PubMed ID: 23376805
[TBL] [Abstract] [Full Text] [Related]
3. Effect of neuraxial anaesthesia on tumour progression in cervical cancer patients treated with brachytherapy: a retrospective cohort study.
Ismail H; Ho KM; Narayan K; Kondalsamy-Chennakesavan S
Br J Anaesth; 2010 Aug; 105(2):145-9. PubMed ID: 20573631
[TBL] [Abstract] [Full Text] [Related]
